Additional details on the meeting can be found at the WORLD Symposium website. About Spur Therapeutics Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing ...
England’s NHS will routinely fund Sanofi/Genzyme’s Cerdelga (eliglustat) for the rare condition Gaucher disease after ... Cerdelga for treating type 1 disease. Genzyme had offered a further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback